ZA987018B - Eprosartan arginyl complex and a process for its production and formational - Google Patents

Eprosartan arginyl complex and a process for its production and formational

Info

Publication number
ZA987018B
ZA987018B ZA987018A ZA987018A ZA987018B ZA 987018 B ZA987018 B ZA 987018B ZA 987018 A ZA987018 A ZA 987018A ZA 987018 A ZA987018 A ZA 987018A ZA 987018 B ZA987018 B ZA 987018B
Authority
ZA
South Africa
Prior art keywords
formational
complex
production
eprosartan
arginyl
Prior art date
Application number
ZA987018A
Other languages
English (en)
Inventor
Manga R Gudipati
Gopadi M Venkatesh
Nageswara R Palepu
John M Jushchyshyn
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ZA987018B publication Critical patent/ZA987018B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA987018A 1997-08-06 1998-08-05 Eprosartan arginyl complex and a process for its production and formational ZA987018B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5499097P 1997-08-06 1997-08-06

Publications (1)

Publication Number Publication Date
ZA987018B true ZA987018B (en) 1999-02-08

Family

ID=21994861

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA987018A ZA987018B (en) 1997-08-06 1998-08-05 Eprosartan arginyl complex and a process for its production and formational

Country Status (27)

Country Link
EP (1) EP1027047B1 (fr)
JP (1) JP4463975B2 (fr)
KR (1) KR100508044B1 (fr)
CN (1) CN1276724A (fr)
AR (1) AR015930A1 (fr)
AT (1) ATE341325T1 (fr)
AU (1) AU739295B2 (fr)
BR (1) BR9811926A (fr)
CA (1) CA2299470C (fr)
CO (1) CO4960666A1 (fr)
CY (1) CY1105851T1 (fr)
CZ (1) CZ296274B6 (fr)
DE (1) DE69836095T2 (fr)
DK (1) DK1027047T3 (fr)
ES (1) ES2273433T3 (fr)
HK (1) HK1031688A1 (fr)
HU (1) HUP0201624A3 (fr)
IL (1) IL134378A (fr)
NO (1) NO317771B1 (fr)
NZ (1) NZ502644A (fr)
PL (1) PL198875B1 (fr)
PT (1) PT1027047E (fr)
SA (1) SA98190592B1 (fr)
TR (1) TR200000350T2 (fr)
TW (1) TW570921B (fr)
WO (1) WO1999007365A1 (fr)
ZA (1) ZA987018B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA991922B (en) * 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
MXPA01010923A (es) * 1999-04-28 2002-06-21 Takeda Chemical Industries Ltd Composicion farmaceutica para prevenir, tratar o inhibir la evolucion de la retinopatia simple y la retinopatia preproliferativa.
EP1604664A4 (fr) 2003-01-31 2006-12-27 Sankyo Co Medicament pour la prevention et le traitement de l'arteriosclerose et de l'hypertension
NO323391B1 (no) 2005-09-28 2007-04-23 Hts Hans Torgersen & Sonn As Barnepose
EP2167047A2 (fr) * 2007-06-06 2010-03-31 Dexcel Ltd. Procédé de formation de formes posologiques orales solides dans des antagonistes du récepteur de l'angiotensine ii
JP5476782B2 (ja) * 2009-04-21 2014-04-23 大正製薬株式会社 アルギニン含有錠剤の製造方法
JP5446716B2 (ja) * 2009-10-21 2014-03-19 大正製薬株式会社 アルギニン及びカルニチン含有錠剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
WO1992010189A1 (fr) * 1990-12-14 1992-06-25 Smithkline Beecham Corporation Acides imidazolyl-alcenoiques
DK0565634T3 (da) * 1990-12-14 1999-09-27 Smithkline Beecham Corp Angiotensin-II-receptorblokkersammensætninger
US5187159A (en) * 1991-10-07 1993-02-16 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
FR2688781B1 (fr) * 1992-03-23 1994-07-01 Sanofi Elf Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
DE4210787A1 (de) * 1992-04-01 1993-10-07 Bayer Ag Cycloalkyl- und Heterocyclyl substituierte Imidazolylpropensäurederivate
JPH0841053A (ja) * 1994-07-28 1996-02-13 Nkk Corp ヘテロアリールアルキル基を有するピリミジン誘導体及 び該誘導体を有効成分として含有するアンジオテンシン ｉｉ拮抗剤
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
PL327397A1 (en) * 1995-12-14 1998-12-07 Merck & Co Inc Antagonists of a gonadothropin liberating hormone

Also Published As

Publication number Publication date
EP1027047B1 (fr) 2006-10-04
SA98190592B1 (ar) 2006-06-20
KR100508044B1 (ko) 2005-08-17
ES2273433T3 (es) 2007-05-01
HUP0201624A2 (hu) 2002-12-28
BR9811926A (pt) 2000-08-22
CN1276724A (zh) 2000-12-13
CO4960666A1 (es) 2000-09-25
CZ2000406A3 (cs) 2000-09-13
JP2001513498A (ja) 2001-09-04
AU739295B2 (en) 2001-10-11
CA2299470C (fr) 2010-01-26
CA2299470A1 (fr) 1999-02-18
IL134378A0 (en) 2001-04-30
TW570921B (en) 2004-01-11
AR015930A1 (es) 2001-05-30
JP4463975B2 (ja) 2010-05-19
KR20010022582A (ko) 2001-03-26
CY1105851T1 (el) 2011-02-02
HUP0201624A3 (en) 2003-03-28
AU8768898A (en) 1999-03-01
NZ502644A (en) 2002-03-01
NO20000577D0 (no) 2000-02-04
TR200000350T2 (tr) 2000-12-21
ATE341325T1 (de) 2006-10-15
PL198875B1 (pl) 2008-07-31
CZ296274B6 (cs) 2006-02-15
NO20000577L (no) 2000-02-29
IL134378A (en) 2004-02-19
PL341562A1 (en) 2001-04-23
WO1999007365A1 (fr) 1999-02-18
HK1031688A1 (en) 2001-06-22
EP1027047A1 (fr) 2000-08-16
EP1027047A4 (fr) 2002-09-18
DE69836095T2 (de) 2007-04-12
PT1027047E (pt) 2007-01-31
DK1027047T3 (da) 2007-01-29
NO317771B1 (no) 2004-12-13
DE69836095D1 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
ZA9811630B (en) Process for manufacturing bite-dispersion tablets
ZA972686B (en) Eprosartan dihydate and a process for its production and formulation.
CY2551B1 (en) Process for preparing eprosartan
CY2555B1 (en) Process for preparing eprosartan
EP0919603A4 (fr) Procede de production d'un article etiquete
SG65049A1 (en) Process for the production of polyther polyols
GB9523387D0 (en) Production process
ZA987018B (en) Eprosartan arginyl complex and a process for its production and formational
PL327946A1 (en) Novel production process
GB9819651D0 (en) Matrerial and process for its production
GB9709762D0 (en) Production process
SG72861A1 (en) Process for producing 7-octen-1-al
HUP9802955A3 (en) Process for producing amino-cyano-acetamide
EP0990658A4 (fr) Procede de production de trihydrocarbylaluminums
SI1027047T1 (sl) Arginil kompleks eprosartana za nevtralizacijo naboja in postopek za njegovo izdelavo in formulacijo
GB9602805D0 (en) Production process
IL120802A0 (en) A process for encapsulating laygon
GB9711802D0 (en) Process for confectionery production
AU9436398A (en) Caprolactam production process
HU9801800D0 (en) Process for producing 1-pyruvyl-l-proline
GB9705507D0 (en) Production process
GB9724095D0 (en) New process for morphine-6-glucuronide production
HUP0002670A3 (en) Process for preparing etoposide
GB9615770D0 (en) Production process
GB9604097D0 (en) Production process